Export

EN
FR
Hydrocortisone
Essential medicine status
Section:
18. Medicines for endocrine disorders 18.1. Adrenal hormones and synthetic substitutes
ATC codes: H02AB09
EMLc
Indication
Adrenocortical insufficiency ICD11 code: 5A74
INN
Hydrocortisone
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Solid > tablet: 5 mg ; 10 mg ; 20 mg
Oral > Solid > granules: 0.5 mg in capsule (EMLc) ; 1 mg in capsule (EMLc) ; 2 mg in capsule (EMLc) ; 5 mg in capsule (EMLc)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Removed in 2003 (TRS 920)
Added in 2009 (TRS 958)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Hydrocortisone
DrugBank
Hydrocortisone
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of hydrocortisone granules (in capsule) 0.5 mg, 1 mg, 2 mg and 5 mg to the EMLc for the treatment of adrenal insufficiency.